Angela Nam
About Angela Nam
Eun (Angela) Nam is FTAI Aviation’s Chief Financial Officer since August 2022 and Chief Accounting Officer since August 2018; she is 43, holds a BBA in Finance and Accounting from Emory University, and is a CPA, with prior roles at Fortress (Private Equity) and KPMG. She became an employee of FTAI upon internalization on May 28, 2024; her 2025 incentive design ties pay to Adjusted EBITDA (75%) and individual goals (25%), and long-term PSUs measured by relative TSR vs the S&P 400 and adjusted EPS over three years. In 2024, Aerospace Products generated $1.0 billion of revenue (~5% market share), and equity award values used a $144.04 closing share price on 12/31/24 for valuation reference. These features indicate a pay-for-performance framework emphasizing profitability and shareholder returns alongside strict anti-hedging/anti-pledging and clawback policies.
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| FTAI Aviation Ltd. | Chief Financial Officer | Aug 2022 – Present | Senior finance leadership through internalization and growth initiatives |
| FTAI Aviation Ltd. | Chief Accounting Officer | Aug 2018 – Present | Oversight of accounting and reporting |
| Fortress Private Equity Group | Senior Vice President | 2014 – May 2024 | Led/involved in M&A and capital markets transactions |
| Drive Shack Inc. | Interim Chief Accounting Officer | Mar – Sep 2016 | Accounting transition at Fortress-managed entity |
| KPMG LLP | Audit & Risk Advisory Services | >10 years pre-2014 | Audit and risk advisory experience |
Fixed Compensation
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Base Salary ($) | $200,000 | $200,000 | $525,000 |
| Bonus ($) | $900,000 | $1,250,000 | $1,000,000 |
| Stock Awards ($) | — | — | $3,413,462 |
| All Other Compensation ($) | $9,560 | $10,310 | $11,514 |
| Total ($) | $1,109,560 | $1,460,310 | $4,949,976 |
| 2025 Annual Compensation Structure | Details |
|---|---|
| Base Salary | $525,000 (unchanged) |
| Target Bonus | $525,000; payout range 0–200% |
| Annual Bonus Metrics/Weights | Adjusted EBITDA (75%), Individual performance (25%) |
| Benefits | 401(k) safe harbor; company-paid life insurance |
Perquisites noted (2024): 401(k) matching $10,350 and life insurance premiums $1,164.
Performance Compensation
Annual Bonus Plan
| Year | Target Bonus ($) | Metrics/Weighting | Actual Payout ($) |
|---|---|---|---|
| 2024 | $800,000 (discretionary) | No pre-set goals post-internalization; committee’s subjective assessment of Company and individual performance | $1,000,000 |
| 2025 | $525,000 | Adjusted EBITDA (75%) + Individual (25%); 0–200% payout range | TBD |
RSUs (Time-based)
| Award | Grant Date | Shares (#) | Vesting Schedule | Grant-Date Fair Value ($) | Acceleration Terms |
|---|---|---|---|---|---|
| Internalization RSUs | May 28, 2024 | 6,224 | Three equal annual installments on May 28, 2025/2026/2027 | $526,862 | Full vest on termination without cause/for good reason, or death/disability |
Outperformance PSUs (One-time, TSR-based)
| Grant Date | Threshold (#) | Target (#) | Maximum (#) | Performance Metric | Performance Period | Post-Performance Vesting |
|---|---|---|---|---|---|---|
| Nov 4, 2024 | 6,000 | 15,000 | 60,000 | Annualized TSR (CAGR) with rigorous tiers | Nov 5, 2024 – Nov 5, 2027 | Earned PSUs vest in thirds on Nov 5, 2027/2028/2029 |
PSU tier schedule:
| Performance Level | Annualized TSR (CAGR) | Value Created for Shareholders ($B) | Payout (% of Target) |
|---|---|---|---|
| Tier 1 (Max) | ≥30% | ≥$16.7B | 400% |
| Tier 2 | 25% | $13.3B | 200% |
| Tier 3 | 20% | $10.2B | 100% |
| Tier 4 (Threshold) | 15% | $7.3B | 40% |
| Below Threshold | <15% | <$7.3B | 0% |
2025 Long-Term Equity Program (Structured)
| Component | Weight | Metrics |
|---|---|---|
| RSUs | 50% of target grant value | Three-year ratable vesting (annual installments) |
| PSUs | 50% of target grant value | Relative TSR vs S&P 400 (50%) and adjusted EPS (50%) over three years; 0–200% earn-out |
Equity Ownership & Alignment
| Holder | Beneficial Ownership (Shares) | Percent of Class |
|---|---|---|
| Eun (Angela) Nam | 4,575 | <1% (denoted by “*”) |
Outstanding equity awards as of 12/31/24:
| Award | Unvested/Unearned Shares (#) | Market/Payout Value ($) |
|---|---|---|
| RSUs (Internalization) | 6,224 | $896,505 (at $144.04 close) |
| PSUs (Outperformance, threshold assumption) | 6,000 | $864,240 (at $144.04 close) |
- Anti-hedging and anti-pledging: Executives are prohibited from hedging and pledging Company stock (margin accounts and pledges prohibited; limited exceptions may be granted).
- Clawback: Incentive comp recoverable in restatements; committee may recoup time-based equity in cases of gross misconduct contributing to restatement.
- Option practices: Post-internalization, the Company does not grant options/SARs; repricing/cash buyouts of option-like awards prohibited under the 2025 Plan.
Employment Terms
| Provision | Key Terms |
|---|---|
| Offer Letter Date | May 27, 2024 (effective with internalization May 28, 2024) |
| Base Salary | $525,000 (2024 and unchanged for 2025) |
| Target Bonus | $800,000 (2024 discretionary); $525,000 (2025 structured) |
| Non-Compete | 12 months after termination for cause or resignation other than for good reason |
| Non-Solicit | 18 months following termination for any reason |
| Severance (outside CIC) | 1.0x base + annual target bonus, paid ratably over one year; Prior Year Bonus; 18 months health/dental/vision reimbursement; equity acceleration as described |
| Severance (within CIC period) | 2.0x base + annual target bonus, lump sum; CIC pro‑rata bonus; Prior Year Bonus; 24 months health reimbursement; equity acceleration |
| Death/Disability | Prior Year Bonus; equity acceleration; CIC pro‑rata bonus if within CIC period |
| Good Reason (summary) | Material adverse change in role/reporting; material Company breach; material salary reduction (>10% not broad-based); relocation outside NYC; failure by successor to assume offer letter |
| Equity Acceleration – RSUs | Internalization RSUs fully vest upon termination without cause/for good reason/death/disability |
| Equity Acceleration – Outperformance PSUs | If terminated without cause/for good reason before performance period ends, earned PSUs remain and one-third vests on Nov 5, 2027; after performance period, next tranche vests immediately; death/disability during performance period → full earned amount vests on Nov 5, 2027 (amounts shown assume threshold 10%) |
Investment Implications
- Pay-for-performance alignment improving: 2025 design ties 75% of annual incentives to Adjusted EBITDA and 50% of PSUs to relative TSR with the remainder to adjusted EPS, while one-time Outperformance PSUs require exceptional TSR (15–30% CAGR) and large shareholder value creation ($7.3–$16.7B), sharpening alignment but increasing performance pressure.
- Retention risk mitigants: Non-compete/non-solicit covenants, meaningful equity acceleration mechanics, and CIC severance at 2.0x base+bonus reduce voluntary departure risk, especially through 2027–2029 vesting cadence.
- Insider selling pressure: RSU vesting dates on May 28, 2025/2026/2027 and potential PSU vesting on Nov 5, 2027/2028/2029 create predictable liquidity windows; anti-hedging/anti-pledging reduces leverage-related selling risks.
- Ownership “skin in the game”: Direct beneficial ownership is modest (<1%), but unvested RSUs and performance PSUs provide substantial exposure to equity outcomes; clawback coverage adds governance discipline.
- Governance quality: No single-trigger vesting, no excise tax gross-ups, prohibition on option repricing, and adoption of a clawback policy indicate shareholder-friendly plan features; the Compensation Committee engaged an independent consultant to implement structured 2025 programs.
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks